{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:36:49Z","timestamp":1788871009842,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Swedish Pharmaceutical Society"},{"DOI":"10.13039\/501100006592","name":"Gustaf Th Ohlsson Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006592","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ijpharm.2015.02.045","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T04:42:43Z","timestamp":1424407363000},"page":"246-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Do surface active parenteral formulations cause inflammation?"],"prefix":"10.1016","volume":"484","author":[{"given":"Lars","family":"S\u00f6derberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Engblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lanbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Wahlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2015.02.045_bib0005","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10856-006-0444-8","article-title":"Surface behavior of biomaterials: the theta surface for biocompatibility","volume":"17","author":"Baier","year":"2006","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0272-0590(86)90248-4","article-title":"Pain on injection and muscle irritation: a comparison of animal models for assessing parenteral antibiotics","volume":"6","author":"Comereski","year":"1986","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0015","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI104778","article-title":"Massive thrombosis produced by fatty acid infusion","volume":"42","author":"Connor","year":"1963","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.CIR.75.3.533","article-title":"Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patient with septic shock","volume":"75","author":"Dhainaut","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0952-3278(99)80022-2","article-title":"Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster","volume":"60","author":"Egan","year":"1999","journal-title":"Prostagl. Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0300-483X(80)90056-6","article-title":"Biological effect of surfactants, IV. Effects of non-ioninc and amphoterics on HeLa cells","volume":"15","author":"Ernst","year":"1980","journal-title":"Toxicology"},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00330108","article-title":"Toxicological properties of surfactants","volume":"32","author":"Gloxhuber","year":"1974","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0040","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(87)91013-0","article-title":"Erythrocyte crenation induced by free fatty acids in patients undergoing extracorporeal circulation","volume":"2","author":"Kamada","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.13172\/2052-9651-1-1-602","article-title":"Transitions between lamellar and non-lamellar phases in membrane lipids and their physiological roles","volume":"1","author":"Koynova","year":"2013","journal-title":"OA Biochem."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(66)92420-2","article-title":"Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion","volume":"2","author":"Kurien","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0773.1995.tb01043.x","article-title":"Cytotoxic effects of four antibiotics on endothelial cells","volume":"77","author":"Lanbeck","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0060","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1034\/j.1600-0773.2001.d01-105.x","article-title":"Short-term effects of four antibiotics on DNA synthesis in endothelial cells","volume":"88","author":"Lanbeck","year":"2001","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0065","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/00365540110080908","article-title":"Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study","volume":"34","author":"Lanbeck","year":"2002","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/jac\/dkh056","article-title":"Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cell: a possible factor in the pathogenesis of infusion phlebitis","volume":"53","author":"Lanbeck","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0075","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/000456328802500512","article-title":"Individual free fatty acids and lactate uptake in the human heart during severe sepsis","volume":"25","author":"Lefevre","year":"1988","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0080","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJMra054035","article-title":"Trans-fatty acids and cardiovascular diseases","volume":"354","author":"Mozaffarian","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0085","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/bja\/85.4.599","article-title":"The role of albumin in critical illness","volume":"85","author":"Nicholson","year":"2000","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.45.2.491","article-title":"Metabolic responses during impending myocardial infarction. II. Clinical implications","volume":"45","author":"Oliver","year":"1972","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0773.1961.tb00323.x","article-title":"Pharmacological effects of fatty acids, triolein and cottonseed oil","volume":"18","author":"Or\u00f6","year":"1961","journal-title":"Acta Pharmacol. Toxicol. (Copenh.)"},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1620\/tjem.127.301","article-title":"Physico-chemical properties and local toxic effects of injectables","volume":"127","author":"Oshida","year":"1979","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/bj0530177","article-title":"The physical chemistry of haemolysis by surface-active agents","volume":"53","author":"Pethica","year":"1953","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0110","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1172\/JCI118742","article-title":"Mechanism of free fatty acids-induced insulin resistance in humans","volume":"97","author":"Roden","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0115","first-page":"51","article-title":"Phlebitis associated with peripheral cannulae","volume":"12","author":"Stonehouse","year":"1996","journal-title":"Prof. Nurse"},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0120","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1023\/A:1016075412098","article-title":"Predicting injection site muscle damage I: evaluation of immediate release parenteral formulations in animal models","volume":"13","author":"Sutton","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0125","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1600-0773.1983.tb01104.x","article-title":"Local muscle damages and oily vehicles: a study on local reactions in rabbit after intramuscular injection of neuroleptic drugs in aqueous or oily vehicles","volume":"52","author":"Svendsen","year":"1983","journal-title":"Acta Pharmacol. Toxicol. (Copenh.)"},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0773.1985.tb01273.x","article-title":"Test for local toxicity of intramuscular drug preparations: comparison of in vitro and in vivo methods","volume":"56","author":"Svendsen","year":"1985","journal-title":"Acta Pharmacol. Toxicol. (Copenh.)"},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00000542-200601000-00017","article-title":"Ultralong peripheral nerve block by lidocaine:prilocaine 1:1 mixture in a lipid depot formulation: comparison of in vitro, in vivo and effect kinetics","volume":"104","author":"S\u00f6derberg","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0140","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ejps.2008.11.011","article-title":"The effects of lipophilic substances on the shape of erythrocytes demonstrated by a new in-vitro method","volume":"2","author":"S\u00f6derberg","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2015.02.045_bib0145","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s10637-011-9730-5","article-title":"Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019) through iterative chemical redesign: mechanisms and pathways to cell death","volume":"30","author":"Wasik","year":"2012","journal-title":"Invest. New Drugs"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517315001544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517315001544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T19:49:45Z","timestamp":1589485785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517315001544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0378517315001544"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.02.045","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do surface active parenteral formulations cause inflammation?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.02.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}